{"nct_id":"NCT03911869","title":"An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis","status":"TERMINATED","status_verified_date":"2023-05","start_date":"2019-04-30","start_date_type":"ACTUAL","primary_completion_date":"2022-01-27","primary_completion_date_type":"ACTUAL","completion_date":"2022-01-27","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}